Reasons for refusal of the human papillomavirus vaccine among young cancer survivors.

ABSTRACT:

Background

Cancer survivors are at risk for developing subsequent human papillomavirus (HPV)-related malignancies. HPV vaccination rates among survivors remain low, and the reasons for refusal of the vaccine are unclear in this population.

Methods

The authors conducted a secondary analysis of data from an open-label clinical trial evaluating the immunogenicity and safety of the HPV vaccine among vaccine-naive cancer survivors who were 9-26 years old and 1-5 years from the completion of their cancer treatment. Survivors/parents who declined trial participation were asked their reasons for declining. Refusal reasons were categorized, and multivariable logistic regression models were developed to identify associations between survivor characteristics and primary refusal reasons

SUBMITTER: Cherven B 

PROVIDER: S-EPMC10283160 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature